These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7140805)

  • 1. Modification in the pharmacokinetics of amikacin during development.
    Lanao JM; Dominguez-Gil A; Dominguez-Gil AA; Málaga S; Crespo M; Nuño F
    Eur J Clin Pharmacol; 1982; 23(2):155-60. PubMed ID: 7140805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and dose calculations of amikacin in the newborn.
    Sardemann H; Colding H; Hendel J; Kampmann JP; Hvidberg EF; Vejlsgaard R
    Clin Pharmacol Ther; 1976 Jul; 20(1):59-66. PubMed ID: 1277725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period.
    Assael BM; Parini R; Rusconi F; Cavanna G
    Pediatr Res; 1982 Oct; 16(10):810-5. PubMed ID: 7145504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose amikacin kinetics in pediatric oncology patients.
    Kramer WG; Cleary T; Frankel LS; Kohl S; Pickering LK
    Clin Pharmacol Ther; 1979 Nov; 26(5):635-40. PubMed ID: 498705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.
    Regeur L; Colding H; Jensen H; Kampmann JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):214-8. PubMed ID: 848923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin pharmacokinetics in pediatric patients with malignancy.
    Cleary TG; Pickering LK; Kramer WG; Culbert S; Frankel LS; Kohl S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):829-32. PubMed ID: 533263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases.
    Howard JB; McCraken GH; Trujillo H; Mohs E
    Antimicrob Agents Chemother; 1976 Aug; 10(2):205-10. PubMed ID: 984762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular levels of amikacin after intravenous administration.
    Yogev R; Kolling WM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):583-6. PubMed ID: 7325626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of amikacin and cephalothin in bedridden elderly patients.
    Yasuhara H; Kobayashi S; Sakamoto K; Kamijo K
    J Clin Pharmacol; 1982; 22(8-9):403-9. PubMed ID: 7130429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study.
    Dyas A; Wise R; Pijck J; Hallynck T; Acar J; Adam D; Cadorniga R; Wenk M; Soep HH
    J Antimicrob Chemother; 1983 Oct; 12(4):371-6. PubMed ID: 6643332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin pharmacokinetics in young men with pneumonia.
    Bauer LA; Blouin RA
    Clin Pharm; 1982; 1(4):353-5. PubMed ID: 7185529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.